Skip to main content

Table 2 Association between sarcopenia components and RAGE in gender difference using linear regression analysis

From: Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study

Gender Variables RAGE
Crude β coefficients
(95% CI)
P Value Adjusted β coefficients
(95% CI)
P Value
All Low muscle mass 162.80 (36.44, 289.16) 0.012 164.04 (36.02, 292.06) 0.012
Low muscle strength 181.31 (28.90, 333.71) 0.020 216.71 (50.88, 382.54) 0.011
Low gait speed − 157.24 (−324.85, 10.38) 0.066 − 155.84 (− 331.54, 20.37) 0.083
Male Low muscle mass 69.51 (− 112.77, 251.78) 0.452 27.51 (− 159.62, 214.64) 0.772
Low muscle strength 61.68 (− 183.08, 306.44) 0.619 −38.42 (− 323.85, 247.02) 0.790
Low gait speed − 165.77 (− 392.22, 60.68) 0.150 − 264.37 (− 501.42, − 27.32) 0.029
Female Low muscle mass 221.72 (45.51, 397.93) 0.014 239.47 (65.45, 413.48) 0.007
Low muscle strength 208.68 (7.04, 410.31) 0.043 303.28 (99.41, 507.14) 0.004
Low gait speed − 142.96 (− 388.08, 102.16) 0.251 −71.93 (− 325.17, 181.32) 0.576
  1. aAdjusted covariates: age, sex, smoking, comorbidities (hypertension, diabetes mellitus, myocardial infarction, angina, coronary artery disease, and chronic obstructive pulmonary disease)